Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. Announces Management Changes
The Board also announced that it proposes to appoint Ms. Yu Xiao Yang as a non-executive Director of the fourth session of the Board; Mr. Zhou Zhong Hui as an independent non-executive Director of the fourth session of the Board; Mr. Zhao Wen Bin and Mr. Li Ning Jian as Supervisors of the fourth session of the Supervisory Committee. The proposed appointment of Directors and Supervisors are subject to approval by the shareholders of the company at the 2012 AGM. Ms. Yu Xiao Yang is a Founding Partner of China New Enterprise Investment (CNEI) and has over 20 years of banking and investment experience. She served at Paris Bank in Geneva, Dresdner Bank in Frankfurt, London and New York, and Salomon Brothers in New York. Mr. Zhou Zhong Hui is a member of the International Advisory Committee of the China Securities Regulatory Commission, the Audit Regulation Committee of Chinese Institution of Certified Public Accountant and the managing director of China Appraisal Society. He used to be the Chief Accountant of the China Securities Regulatory Commission, the Senior Partner and General Manager and Director of accountant of PricewaterhouseCoopers Zhong Tian CPAs Limited Company and the Professor of Shanghai University of Finance and Economics. He has been an independent director of BesTV New Media Co. Ltd. since 23 December 2011. Mr. Zhao Wen Bin is currently the managing director of Shanghai Fudan Holdings Co. Ltd. He used to be deputy managing director of the Enterprise Incubation & Equity Management Office of Fudan University, the secretary of Fudan Charity Fund, deputy director of Student Service Union, deputy secretary of Fudan University Committee of the Communist Youth League, etc. Mr. Li Ning Jian has years of experience in venture capital and securities investment. He is currently the senior investment manager of Shanghai Pudong Science and Technology Investment Co. Ltd.